5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

被引:46
作者
Kuroki, T
Meltzer, HY
Ichikawa, J
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 8128582, Japan
[2] Vanderbilt Univ, Sch Med, Psychopharmacol Div, Dept Psychiat, Nashville, TN 37212 USA
[3] Vanderbilt Univ, Sch Med, Psychopharmacol Div, Dept Pharmacol, Nashville, TN 37212 USA
关键词
1-(2,5-dimethoxy-4-iodophenyl)-aminopropane]-hydrochloride; M100907; 5-HT2A receptor; amphetamine; dopa-mine; microdialysis; rat;
D O I
10.1016/S0006-8993(03)02516-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
(+/-)-([1-(2,5-Dimethoxy-4-iodophenyl)-aminopropane]-hydrochloride) (DOI) (2.5 mg/kg), a 5-HT2A/2C agonist, significantly potentiated D-amphetamine (AMPH) (1 mg/kg)-induced dopamine (DA) release in rat medial prefrontal cortex (mPFC) and nucleus accumbens (NAC). This effect of DOI was completely prevented by M100907 (1 mg/kg), a selective 5-HT2A antagonist, which by itself had no effect on basal and AMPH-induced DA release in either region. Thus, 5-HT2A receptor agonism potentiates AMPH-induced DA release in the mPFC and NAC. (C) 2003 Elsevier Science B,V. All rights reserved.
引用
收藏
页码:216 / 221
页数:6
相关论文
共 43 条
[1]   5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex [J].
Abi-Saab, WM ;
Bubser, M ;
Roth, RH ;
Deutch, AY .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (01) :92-96
[2]   SR46349-B, a 5-HT2A/2c receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens [J].
Bonaccorso, S ;
Meltzer, HY ;
Li, Z ;
Dai, J ;
Alboszta, AR ;
Ichikawa, J .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (03) :430-441
[3]   Serotonin 5-HT2 receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat [J].
Bowers, BJ ;
Henry, MB ;
Thielen, RJ ;
McBride, WJ .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (04) :1625-1633
[4]   Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method [J].
Breier, A ;
Su, TP ;
Saunders, R ;
Carson, RE ;
Kolachana, BS ;
de Bartolomeis, A ;
Weinberger, DR ;
Weisenfeld, N ;
Malhotra, AK ;
Eckelman, WC ;
Pickar, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2569-2574
[5]   Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens [J].
Carr, DB ;
O'Donnell, P ;
Card, JP ;
Sesack, SR .
JOURNAL OF NEUROSCIENCE, 1999, 19 (24) :11049-11060
[6]  
Cornea-Hébert V, 1999, J COMP NEUROL, V409, P187, DOI 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO
[7]  
2-P
[8]   Role of serotonin2A and serotonin2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation [J].
De Deurwaerdère, P ;
Spampinato, U .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1033-1042
[9]   BINDING OF PHENYLALKYLAMINE DERIVATIVES AT 5-HT1C AND 5-HT2 SEROTONIN RECEPTORS - EVIDENCE FOR A LACK OF SELECTIVITY [J].
GLENNON, RA ;
RAGHUPATHI, R ;
BARTYZEL, P ;
TEITLER, M ;
LEONHARDT, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (04) :734-740
[10]   Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats [J].
Gobert, A ;
Millan, MJ .
NEUROPHARMACOLOGY, 1999, 38 (02) :315-317